BiotechTube
Home/Lys Therapeutics/Pr. Denis Vivien
PD

Pr. Denis Vivien

Co-founder, Head of Science, SAB President

Lys Therapeutics

Therapeutic Areas

NeurologyNeurodegenerative DiseasesNeurovascular Diseases

Lys Therapeutics Pipeline

DrugIndicationPhase
LYS241Parkinson's Disease, Stroke, Multiple SclerosisPre-clinical

Leadership Team at Lys Therapeutics

DM
Dr. Manuel Blanc
Co-founder, CEO & President
PD
Philippe Dujardin
Co-founder, CFO
MV
Michel Vounatsos
Chairman of the Board
View full Lys Therapeutics profile